Show results for
Refine by
Clinical Stage Suppliers Serving Belarus
126 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
based inSan Francisco, CAMBODIA
Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 healthcare providers. Our specialty medical society partners ...
based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
based inMontpellier, FRANCE
SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes. SurgiMab was ...
based inKaiseraugst, SWITZERLAND
Solvias is a world leader in contract research, development and manufacturing (CRO/CDMO). The industries we serve include pharmaceuticals, biotech, medical devices and cosmetics. We provide integrated analytical services and solutions to the ...
Preformulation Package: Preformulation includes the compiling of solubility profiles (pH dependent and other systems of interest), permeability (logP/D, CaCo2 or other cell-based assays), BCS classification, accelerated chemical stability, basic ...
based inSuwanee, GEORGIA (US) (USA)
Femasys is a biomedical company aiming to meet women’s needs worldwide with a novel suite of product candidates that include minimally invasive, in-office technologies for reproductive health. Femasys is working to provide next generation ...
FemBloc features our proprietary delivery platform, which places balloon technology close to the opening of both fallopian tubes. This in-office approach is designed to eliminate the risks of incisions, anesthesia, and hormones. As a nonsurgical ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
based inSalt Lake City, UTAH (USA)
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics’ cell isolation ...
based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
based inSchlieren, SWITZERLAND
Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and metabolic functions that are essential for the host and the microbiome. PharmaBiome has developed ...
based inBrooklyn, NEW YORK (USA)
Synchron, an endovascular brain interface company, is a leader in implantable neural interface technology. The clinical-stage company is developing a neuroprosthesis for the treatment of paralysis and the first endovascular implantable ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer agent and also a selective agonist of GPR132. ONC212 also induces ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
The SIK program is a strategic effort to develop assets inhibiting salt-inducible kinases (SIK) as a novel target class in inflammation which we discovered with our proprietary target discovery platform. These molecules inhibit the different members ...
based inPrinceton, NEW JERSEY (USA)
Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care. Our technology is based ...
based inNew Hope, PENNSYLVANIA (USA)
We are a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine. Our partnership-enabled business model focuses on forging strategic collaborations with ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
During ReGen’s discussions with potential licensing partners in 2004, it became apparent that a product based on the Colostrinin™ complex, as a whole, was more commercially attractive as a nutraceutical, rather than as a pharmaceutical. ...
based inWarszawa, POLAND
NeuroDevice Group is a clinical stage company working on the development and implementation of projects from various fields of neuroscience. We develop technology enabling innovative therapy for patients suffering from nervous system disorders using ...